HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liangwu Zhuang Selected Research

Cisplatin (Platino)

10/2021Exosomal miR-21-5p derived from cisplatin-resistant SKOV3 ovarian cancer cells promotes glycolysis and inhibits chemosensitivity of its progenitor SKOV3 cells by targeting PDHA1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liangwu Zhuang Research Topics

Disease

1Neoplasms (Cancer)
10/2021
1Ovarian Neoplasms (Ovarian Cancer)
10/2021

Drug/Important Bio-Agent (IBA)

1Cisplatin (Platino)FDA LinkGeneric
10/2021
1Pyruvate Dehydrogenase (Lipoamide)IBA
10/2021